YG-1699

N/A

Report date: 2024/04/09 18:02:37
NME

Base Information

Drug NameYG-1699
Drug Alias NameYG-1699ABSK-101ABSK101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/glucose cotransporter 1 inhibitorsSodium/glucose cotransporter 2 inhibitors
TargetsSodium/glucose cotransporter 2Sodium/glucose cotransporter 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesYoungene Therapeutics Inc Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesYoungene Therapeutics Inc Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A